ÂÜÀòÂÒÂ×

Karin Jennbacken is a highly experienced Senior Director and Global Project Leader at AstraZeneca, where involvement spans drug projects in the late preclinical discovery phase, particularly focusing on cardiovascular, renal, and metabolic areas with an emphasis on stem cell projects. Prior roles include serving as Director and Team Lead of the Cardiovascular In Vivo Team and as Associate Principal Scientist in both the Heart Failure Department and the Cardiovascular In Vitro Team, contributing extensively to research strategy, project leadership, and collaboration with academia and biotech partners. Karin's academic background includes a PhD in Medicine, a Master of Science in Pharmacy, and a Master of Science in Pharmaceutical Bioscience, all from the University of Gothenburg, complemented by postdoctoral research focused on B-1 lymphocytes and natural IgM antibodies in diabetic models.